297 related articles for article (PubMed ID: 19170172)
21. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
Johnson DE; Powers CN; Rupp G; Frable WJ
Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
[TBL] [Abstract][Full Text] [Related]
22. MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma.
Niemann TH; Hughes JH; De Young BR
Cancer; 1999 Oct; 87(5):295-8. PubMed ID: 10536355
[TBL] [Abstract][Full Text] [Related]
23. Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy.
Solé M; Calvet X; Cuberes T; Maderuelo F; Bruix J; Bru C; Rey MJ; Serna N; Cardesa A
Acta Cytol; 1993; 37(3):309-16. PubMed ID: 8388606
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic significance of aquaporin-1 in liver tumors.
Mazal PR; Susani M; Wrba F; Haitel A
Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
[TBL] [Abstract][Full Text] [Related]
25. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
[TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Lei JY; Bourne PA; diSant'Agnese PA; Huang J
Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
[TBL] [Abstract][Full Text] [Related]
28. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies.
Guindi M; Yazdi HM; Gilliatt MA
Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832
[TBL] [Abstract][Full Text] [Related]
29. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
[TBL] [Abstract][Full Text] [Related]
31. Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy.
Tung WC; Huang YJ; Leung SW; Kuo FY; Tung HD; Wang JH; Hung CH; Lee CM; Changchien CS; Yeh SA; Sun LM; Huang EY; Hsu HC; Wang CJ; Lu SN
Liver Int; 2007 Mar; 27(2):192-200. PubMed ID: 17311613
[TBL] [Abstract][Full Text] [Related]
32. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
Fujiwara M; Kwok S; Yano H; Pai RK
Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical evaluation of liver fine-needle aspirations.
Bedrossian CW; Davila RM; Merenda G
Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
[TBL] [Abstract][Full Text] [Related]
35. Cytologic features and histologic correlations of microacinar and microtrabecular types of well-differentiated hepatocellular carcinoma in fine-needle aspiration biopsy.
Yang GC; Yang GY; Tao LC
Cancer; 2004 Feb; 102(1):27-33. PubMed ID: 14968415
[TBL] [Abstract][Full Text] [Related]
36. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
de Boer WB; Segal A; Frost FA; Sterrett GF
Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
[TBL] [Abstract][Full Text] [Related]
37. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
Anatelli F; Chuang ST; Yang XJ; Wang HL
Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
[TBL] [Abstract][Full Text] [Related]
38. Scan-guided fine needle aspiration biopsy in malignant hepatic disease.
Johansen P; Svendsen KN
Acta Cytol; 1978; 22(5):292-6. PubMed ID: 214983
[TBL] [Abstract][Full Text] [Related]
39. Angiomyolipoma of the liver in fine-needle aspiration biopsies: its distinction from hepatocellular carcinoma.
Cha I; Cartwright D; Guis M; Miller TR; Ferrell LD
Cancer; 1999 Feb; 87(1):25-30. PubMed ID: 10096356
[TBL] [Abstract][Full Text] [Related]
40. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.
Bialecki ES; Ezenekwe AM; Brunt EM; Collins BT; Ponder TB; Bieneman BK; Di Bisceglie AM
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):361-8. PubMed ID: 16527701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]